Posted on June 12, 20236/12/23
Informing Optimal Pricing Strategies with a Comprehensive Modeling Approach
Posted on May 25, 20235/25/23
The Influx of Generic Launches Leaves Narrow Opportunities for Multiple Sclerosis Access
Posted on May 17, 20235/17/23
Integrating the Pillars of Global Pricing Governance
Posted on May 16, 20235/16/23
Seven Challenges Traditional Omnichannel Tactics Cannot Overcome
Posted on May 16, 20235/16/23
The Future of Omnichannel is Here. Don’t Get Left Behind.
Posted on May 10, 20235/10/23
Navigating an Ever-evolving Canadian Market Access and Reimbursement Environment
Posted on May 9, 20235/9/23
From Limitations to Expansions: How Prioritizing Patients’ Speed to Therapy Drives Therapy Adoption
Posted on May 5, 20235/5/23
Case Study: Primary Research Meets Data-Driven Sources and Technology to Form Powerful Market Access Solutions
Posted on April 21, 20234/21/23
Left-Right-Left: The Latest in Pharma-Payer Ping Pong
Posted on April 20, 20234/20/23